At $207 per share in cash and stock, Aetna’s board of directors approved the sale of their company to CVS Health Corp. Share holders, however, will only be getting $145 for each of their shares, and the rest will be made up in CVS shares. THis will mean Aetna shareholders will own roughly 22% of the CVS.
This will be the year’s largest corporate acquisition in the healthcare world. Many are saying that this will allow them to negotiate lower drug prices. Others are denouncing this sale as a move towards monopoly with this vertical merger. Regardless of what others think, the company is planning on investing billions in clinics and services.
